Insider activity at Maxcyte, Inc. has been all selling for a year now: about $8,316 from one seller, and zero buyers with their own money.
Keep in mind most insider selling is routine — stock-based pay has to be converted to cash at some point.
123 investment managers listed MXCT in their latest 13F filings (Q2 2026); more funds bought than sold. Looking at the quarterly pattern: No open-market insider buying or selling in the last full quarter. Insiders bought in 1 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Mar 19, 2026 | Swirsky Douglas J | CFO | Sell | 10,142 | $0.82 | $8K | SEC |
| Aug 27, 2025 | Hemrajani Rekha | Director | Sell | 10,684 | $2.09 | $22K | SEC |
| Aug 13, 2025 | Swirsky Douglas J | CFO | Buy | 50,000 | $1.29 | $64K | SEC |
| Aug 13, 2025 | Masoud Maher | CEO | Buy | 75,000 | $1.37 | $103K | SEC |
| Aug 13, 2025 | Erck Stanley C | Director | Buy | 100,000 | $1.37 | $137K | SEC |
| Aug 13, 2025 | DOUGLAS RICHARD | Director | Buy | 80,000 | $1.39 | $111K | SEC |
| Aug 13, 2025 | Brooke William W | Director | Buy | 50,000 | $1.29 | $64K | SEC |
| Mar 20, 2025 | Soleymannezhad Ali | Executive Officer | Sell | 1,211 | $3.18 | $4K | SEC |
| Mar 20, 2025 | Sandoval David I. | Executive Officer | Sell | 353 | $3.18 | $1K | SEC |
| Mar 20, 2025 | Swirsky Douglas J | CFO | Sell | 6,939 | $3.18 | $22K | SEC |
| Jan 29, 2025 | Johnston John Joseph | Director | Sell | 3,000 | $4.65 | $14K | SEC |
| Jan 14, 2025 | Sandoval David I. | Executive Officer | Sell | 4,466 | $4.54 | $20K | SEC |
| Dec 30, 2024 | Johnston John Joseph | Director | Sell | 3,000 | $4.01 | $12K | SEC |
| Dec 10, 2024 | Johnston John Joseph | Director | Sell | 2,495 | $3.79 | $9K | SEC |
| Dec 10, 2024 | Johnston John Joseph | Director | Sell | 505 | $3.70 | $2K | SEC |
In the last 12 months Maxcyte, Inc. insiders made open-market purchases worth about $0 and sales worth about $8,316. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in MXCT was filed on 2026-03-19.
123 investment managers reported holding MXCT in SEC Form 13F filings for Q2 2026.
No congressional trades in MXCT were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).